# Citi Trends Inc: overview

CTRN · Nasdaq · CIK 1318484 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/ctrn.md) · [Financials](/companies/ctrn/financials.md) · [Filings](/companies/ctrn/filings.md) · [Insiders](/companies/ctrn/insiders.md)

Latest reported revenue: [$211.6m](/filings/0001104659-26-106249.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Sep 9, 2026 (XBRL us-gaap:Revenues, accession 0001104659-26-106249).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [179](/filings/0001104659-25-119960.md) | [211 d](/filings/0001104659-26-043813.md) | [202](/filings/0001104659-26-072225.md) | [191](/filings/0001104659-26-106249.md) | [197](/filings/0001104659-25-119960.md) | [230 d](/filings/0001104659-26-043813.md) | [231](/filings/0001104659-26-072225.md) | [212](/filings/0001104659-26-106249.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(4.9%)](/filings/0001104659-25-119960.md) | [0.6% d](/filings/0001104659-26-043813.md) | [0.2%](/filings/0001104659-26-072225.md) | [1.8%](/filings/0001104659-26-106249.md) | [(3.7%)](/filings/0001104659-25-119960.md) | [3.1% d](/filings/0001104659-26-043813.md) | [3.2%](/filings/0001104659-26-072225.md) | [(0.8%)](/filings/0001104659-26-106249.md) |
| Net margin | % | [(4.0%)](/filings/0001104659-25-119960.md) | [(6.7%) d](/filings/0001104659-26-043813.md) | [0.4%](/filings/0001104659-26-106249.md) | [2.0%](/filings/0001104659-26-106249.md) | [(3.5%)](/filings/0001104659-25-119960.md) | [3.2% d](/filings/0001104659-26-043813.md) | [3.4%](/filings/0001104659-26-106249.md) | [(0.4%)](/filings/0001104659-26-106249.md) |
| Diluted EPS | $ per share | [(0.86)](/filings/0001104659-25-119960.md) | not reported | [0.11](/filings/0001104659-26-072225.md) | [0.46](/filings/0001104659-26-106249.md) | [(0.86)](/filings/0001104659-25-119960.md) | not reported | [0.91](/filings/0001104659-26-072225.md) | [(0.11)](/filings/0001104659-26-106249.md) |
| Free cash flow | $m | [(20.4) d](/filings/0001104659-25-119960.md) | [26.0 d](/filings/0001104659-26-043813.md) | [(13.1)](/filings/0001104659-26-072225.md) | [(1.7) d](/filings/0001104659-26-106249.md) | [0.8 d](/filings/0001104659-25-119960.md) | [14.7 d](/filings/0001104659-26-043813.md) | [15.0](/filings/0001104659-26-072225.md) | [(24.0) d](/filings/0001104659-26-106249.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [992](/filings/0001558370-24-005294.md) | [795](/filings/0001558370-25-004897.md) | [748](/filings/0001104659-26-043813.md) | [753](/filings/0001104659-26-043813.md) | [820](/filings/0001104659-26-043813.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.0%](/filings/0001558370-24-005294.md) | [9.5%](/filings/0001558370-25-004897.md) | [(2.6%)](/filings/0001104659-26-043813.md) | [(5.2%)](/filings/0001104659-26-043813.md) | [0.5%](/filings/0001104659-26-043813.md) |
| Net margin | % | [6.3%](/filings/0001558370-24-005294.md) | [7.4%](/filings/0001558370-25-004897.md) | [(1.6%)](/filings/0001104659-26-043813.md) | [(5.7%)](/filings/0001104659-26-043813.md) | [0.6%](/filings/0001104659-26-043813.md) |
| Diluted EPS | $ per share | [6.91](/filings/0001558370-24-005294.md) | [7.17](/filings/0001558370-25-004897.md) | [(1.46)](/filings/0001104659-26-043813.md) | [(5.19)](/filings/0001104659-26-043813.md) | [0.63](/filings/0001104659-26-043813.md) |
| Free cash flow | $m | [44.6](/filings/0001558370-24-005294.md) | [(16.5)](/filings/0001558370-25-004897.md) | [(24.5)](/filings/0001104659-26-043813.md) | [(14.0)](/filings/0001104659-26-043813.md) | [0.6](/filings/0001104659-26-043813.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ctrn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Fund 1 Investments, LLC](/funds/1959730.md) | 2026-06-30 | $105.5m | 1,823,486 |  | Reduced −750,000 |
| [Divisadero Street Capital Management, LP](/funds/1901865.md) | 2026-06-30 | $40.8m | 705,451 |  | Added +211,405 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $29.4m | 508,301 |  | Added +70,404 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $17.7m | 306,739 |  | Reduced −21,030 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.2m | 245,831 |  | Added +12,668 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $14.1m | 244,328 |  | Unchanged |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $13.8m | 239,003 |  | Added +22,080 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $13.7m | 236,655 |  | Added +13,802 |
| [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $10.3m | 178,106 |  | Added +35,273 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $9.9m | 170,748 |  | Added +62,251 |

## Recent filings

[All 1,076 filings](/companies/ctrn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-11 | 06:58 ET | [8-K](/filings/0001104659-26-106889.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-106889 |
| 2026-09-09 | 13:58 ET | [10-Q](/filings/0001104659-26-106249.md) | Quarterly report, period 2026-08-01 | 0001104659-26-106249 |
| 2026-08-25 | 06:52 ET | [8-K](/filings/0001104659-26-100524.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-100524 |
| 2026-08-10 | 06:52 ET | [8-K](/filings/0001104659-26-093003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093003 |
| 2026-06-25 | 08:46 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001671.md) | Ownership report, active investor, amended | 0000921895-26-001671 |
| 2026-06-12 | 16:15 ET | [8-K](/filings/0001104659-26-073472.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073472 |
| 2026-06-10 | 13:11 ET | [10-Q](/filings/0001104659-26-072225.md) | Quarterly report, period 2026-05-02 | 0001104659-26-072225 |
| 2026-06-02 | 06:58 ET | [8-K](/filings/0001104659-26-069202.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-069202 |
| 2026-05-27 | 16:24 ET | [8-K](/filings/0001104659-26-066966.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-066966 |
| 2026-05-01 | 07:30 ET | [DEF 14A](/filings/0001104659-26-053458.md) | Proxy statement, period 2026-06-10 | 0001104659-26-053458 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001104659-26-043813.md), filed Apr 15, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1318484
- Tickers: CTRN
- Exchange: Nasdaq
- SIC code: 5600 Retail-Apparel & Accessory Stores
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.